CVR: 69720919
The financial health of PHARMACOSMOS HOLDING A/S appears robust, with a significant upward trajectory in both revenue and profit over the past few years. Revenue surged from 2.68 million DKK in 2021 to 58 million DKK in 2025, while profit dramatically increased from a loss of 124 million DKK in 2021 to a profit of 1.65 billion DKK in 2025. The company's equity has also strengthened, rising from 790 million DKK in 2021 to 2.27 billion DKK in 2025, indicating solid financial stability. However, the substantial increase in profit margins raises questions about sustainability, necessitating close monitoring of operational efficiency and market conditions. Overall, PHARMACOSMOS is positioned strongly within the non-financial holding sector, showcasing impressive growth and profitability.
AI-generated summary
Selskabets formål er at drive virksomhed med udvikling af farmaceutiske, kemiske og tekniske produkter og processer og erhverve, eje, disponere og administrere over rettigheder i forbindelse hermed, at eje kapitalandele i selskaber som driver virksomhed med udvikling, produktion og handel med farmaceutiske, kemiske og tekniske produkter, anlæg og lignende, at foretage investeringsvirksomhed og finansiering, herunder anbringelse af kapital i fast ejendom og i virksomheder i ind- og udland, samt efter bestyrelsens skøn at drive anden i forbindelse dermed stående virksomhed.
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | 58 mio. | 1.7 mia. | 2.3 mia. | 2.3 mia. | 0 | |
Compared to 50.000 companies in Ikke-finansielle holdingselskaber
Comparison is based on industry median values
Companies in the same industry and area
CVR 38250868
CVR 34605629
CVR 41021527
CVR 33750099
CVR 27672485
companydata.dk